The use of amino acid based CAPD fluid in chronic renal failure

作者: Gerald A. Young , John B. Dibble , Aleck M. Brownjohn

DOI: 10.1007/978-94-011-2262-7_103

关键词: TransferrinAcidosisInternal medicineEndocrinologyContinuous ambulatory peritoneal dialysisUreaAppetiteChemistryAmino acidPhenylalanineMethionine

摘要: CAPD is a major treatment for end-stage renal disease. A dialysis fluid in the peritoneum, changed several times day, uses glucose, an effective osmotic agent but which contributes to hyperlipidaemia and malnutrition. Amino acids have been investigated as alternative glucose short long-term studies described literature. One two % amino are maximally absorbed into blood after 2–4 h decrease initial concentrations 6 unless constituents excess e.g. phenylalanine methionine. These changes those other metabolites similar marked post-prandial effect. In up 12 weeks duration, one or exchanges of 1% daily were well tolerated with modest nutritional improvement (e.g. acids, transferrin total body nitrogen), small decreases hyperlipidaemia, no clinical problems due loss appetite, increase urea, overhydration acidosis. Both these less favourable suggest could occur higher multiple also unsuitable patients. Slight ultrafiltration increased protein losses dialysate reversible effect on permeability. Our that acid complement activation by pathway generation prostaglandin E2, increases However, exceed all losses, although percentage utilisation not known. based fluids patients high low calorie diets requiring more dialysis. Fluids containing buffering capacity lower certain indicated.

参考文章(17)
Gerald A. Young, John B. Young, Sheila M. Young, Shirley M. Hobson, Bridget Hildreth, Aleck M. Brownjohn, Frank M. Parsons, Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis. Nephron. ,vol. 43, pp. 177- 186 ,(1986) , 10.1159/000183826
T J Williams, P J Jose, Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. Journal of Experimental Medicine. ,vol. 153, pp. 136- 153 ,(1981) , 10.1084/JEM.153.1.136
G.A. Young, A.M. Brownjohn, F.M. Parsons, Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephron. ,vol. 45, pp. 196- 201 ,(1987) , 10.1159/000184116
G.A. Young, S.M. Hobson, S.M. Young, J.B. Young, B. Hildreth, J. Gibson, S.J. Coltman, A.M. Brownjohn, F.M. Parsons, ADVERSE EFFECTS OF HYPERTONIC DIALYSIS FLUID DURING CAPD The Lancet. ,vol. 322, pp. 1421- 1421 ,(1983) , 10.1016/S0140-6736(83)90949-2
ROBERT P. POPOVICH, Continuous Ambulatory Peritoneal Dialysis Annals of Internal Medicine. ,vol. 88, pp. 449- 456 ,(1978) , 10.7326/0003-4819-88-4-449
T. J. WILLIAMS, M. J. PECK, Role of prostaglandin-mediated vasodilatation in inflammation Nature. ,vol. 270, pp. 530- 532 ,(1977) , 10.1038/270530A0
Bengt Lindholm, Andrzej Werynski, Jonas Bergström, Peritoneal dialysis with amino acid solutions: fluid and solute transport kinetics. Artificial Organs. ,vol. 12, pp. 2- 10 ,(2008) , 10.1111/J.1525-1594.1988.TB01516.X
J.M. Ramos, A. Heaton, J.G. McGurk, M.K. Ward, D.N.S. Kerr, Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis. Nephron. ,vol. 35, pp. 20- 23 ,(1983) , 10.1159/000183039
Michele Bruno, Cristiana Bagnis, Martino Marangella, Lidia Rovera, Alberto Cantaluppi, Franco Linari, CAPD with an amino acid dialysis solution: A long-term, cross-over study Kidney International. ,vol. 35, pp. 1189- 1194 ,(1989) , 10.1038/KI.1989.109
J GJESSING, ADDITION OF AMINOACIDS TO PERITONEAL-DIALYSIS FLUID The Lancet. ,vol. 292, pp. 812- ,(1968) , 10.1016/S0140-6736(68)92461-6